Wound dressing
Latest Bristol-Myers Squibb Company Patents:
- Tetrahydropyran-based thiodisaccharide mimics as Galectin-3 inhibitors
- Antibodies Binding to Human PAD4 and Uses Thereof
- Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatment
- Substituted bicyclic compounds useful as T cell activators
- METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR
Description
FIG. 1 is a top plan view of a wound dressing, showing our new design, the broken lines shown are for illustrative purposes only and form no part of the claimed design; and,
FIG. 2 is a bottom surface of a wound dressing, showing our new design.
Claims
We claim the ornamental design for a wound dressing, as shown and described.
Referenced Cited
Patent History
Patent number: D524946
Type: Grant
Filed: Sep 21, 2004
Date of Patent: Jul 11, 2006
Assignee: Bristol-Myers Squibb Company (New York, NY)
Inventors: Helen Louise Shaw (Widnes), Patrick Gerrard Linnane (Chester)
Primary Examiner: Louis S. Zarfas
Assistant Examiner: Daniel Yu
Attorney: John M. Kilcoyne
Application Number: 29/213,608
Type: Grant
Filed: Sep 21, 2004
Date of Patent: Jul 11, 2006
Assignee: Bristol-Myers Squibb Company (New York, NY)
Inventors: Helen Louise Shaw (Widnes), Patrick Gerrard Linnane (Chester)
Primary Examiner: Louis S. Zarfas
Assistant Examiner: Daniel Yu
Attorney: John M. Kilcoyne
Application Number: 29/213,608
Classifications
Current U.S. Class:
Bandage For Protection Or Treatment (53) (D24/189)
